KR230109

Main study objectives: To evaluate the safety and tolerability of KR230109 after single and multiple topical skin administration in healthy adult subjects, and to provide a safety basis for determining the dosage and area of administration used in later trials. Secondary study objectives: To evaluate the systemic exposure level and pharmacokinetic (PK) characteristics of KR230109 after single and multiple topical skin administration in healthy adult subjects.